Anbio Biotechnology Class A Ordinary Shares (NNNN) Stock Analysis

Sector: HEALTHCARE - MEDICAL INSTRUMENTS & SUPPLIES

Exchange: NASDAQ

Key Metrics

• Price: $27.55
• Market Cap: $1.14B
• P/E Ratio: 432.67
• EPS: $0.06
• 52-Week High: $55.65
• 52-Week Low: $5.89

Market Sentiment

Anbio Biotechnology Class A Ordinary Shares currently has a Bullish sentiment score of 0.25.

About Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology Class A Ordinary Shares is a leading developer and distributor of innovative in vitro diagnostic (IVD) products, with a significant global presence across regions including the European Union, Asia Pacific, North America, South America, and Africa. Based in Frankfurt am Main, Germany, the company is dedicated to enhancing healthcare through state-of-the-art diagnostic solutions, positioning itself as a pivotal player in the biotechnology industry. With a comprehensive prod...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Anbio Biotechnology Class A Ordinary Shares and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does NNNN pay dividends?

Anbio Biotechnology Class A Ordinary Shares (NNNN) does not currently pay a regular dividend.

What is NNNN's P/E ratio?

Anbio Biotechnology Class A Ordinary Shares has a price-to-earnings (P/E) ratio of 432.67.

What is NNNN's market cap?

Anbio Biotechnology Class A Ordinary Shares (NNNN) has a market capitalization of $1.14B with a current stock price of $27.55.